• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以宿主细胞为靶点的抗登革病毒方法。

Targeting a host process as an antiviral approach against dengue virus.

机构信息

Department of Genetics and Biochemistry, Clemson University, 217 Biosystems Research Complex, 51 New Cherry Street, Clemson, SC 29634, USA.

出版信息

Trends Microbiol. 2010 Jul;18(7):323-30. doi: 10.1016/j.tim.2010.04.003. Epub 2010 May 6.

DOI:10.1016/j.tim.2010.04.003
PMID:20452219
Abstract

The re-emergence of dengue virus as a significant human pathogen has lead to an increasing need for effective antivirals. Development of therapeutic agents with the ability to attenuate both the duration and severity of disease in patients after infection is particularly desirable in dengue endemic resource-poor settings. The reliance of dengue virus on endogenous processes during the late stages of infection prompts the development of molecules to interfere with and exploit these dependencies as potential antiviral therapies. Here we focus on the importance of N-linked glycan processing in infectious virion morphogenesis.

摘要

登革热病毒作为一种重要的人类病原体再次出现,导致对有效抗病毒药物的需求不断增加。在登革热流行资源匮乏的环境中,开发能够减轻感染后患者疾病持续时间和严重程度的治疗药物是特别需要的。登革热病毒在感染后期依赖于内源性过程,这促使人们开发能够干扰和利用这些依赖性的分子作为潜在的抗病毒治疗方法。在这里,我们重点关注 N-连接糖基化加工在感染性病毒粒子形态发生中的重要性。

相似文献

1
Targeting a host process as an antiviral approach against dengue virus.以宿主细胞为靶点的抗登革病毒方法。
Trends Microbiol. 2010 Jul;18(7):323-30. doi: 10.1016/j.tim.2010.04.003. Epub 2010 May 6.
2
Essential role of dengue virus envelope protein N glycosylation at asparagine-67 during viral propagation.登革病毒包膜蛋白天冬酰胺-67位点的N-糖基化在病毒传播过程中的重要作用。
J Virol. 2007 Jul;81(13):7136-48. doi: 10.1128/JVI.00116-07. Epub 2007 Apr 25.
3
Therapeutic effects of dengue 2 virus capsid protein and staphylococcal nuclease fusion protein on dengue-infected cell cultures.登革2型病毒衣壳蛋白与葡萄球菌核酸酶融合蛋白对登革病毒感染细胞培养物的治疗作用。
Arch Virol. 2005 Apr;150(4):659-69. doi: 10.1007/s00705-004-0451-3. Epub 2004 Dec 10.
4
Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.针对黄病毒的抗病毒抑制剂设计:以登革病毒多功能NS3蛋白为靶点的案例
Antiviral Res. 2008 Nov;80(2):94-101. doi: 10.1016/j.antiviral.2008.07.001. Epub 2008 Jul 30.
5
The medicinal chemistry of dengue fever.登革热的药物化学
J Med Chem. 2009 Dec 24;52(24):7911-26. doi: 10.1021/jm900652e.
6
Capsid-targeted viral inactivation can destroy dengue 2 virus from within in vitro.衣壳靶向的病毒灭活可在体外从内部破坏登革2型病毒。
Arch Virol. 2006 Feb;151(2):379-85. doi: 10.1007/s00705-005-0631-9. Epub 2005 Sep 9.
7
Antiviral activities of sulfonium-ion glucosidase inhibitors and 5-thiomannosylamine disaccharide derivatives against dengue virus.硫鎓离子葡萄糖苷酶抑制剂和 5-硫代甘露糖胺二糖衍生物对登革热病毒的抗病毒活性。
Int J Antimicrob Agents. 2012 Sep;40(3):273-6. doi: 10.1016/j.ijantimicag.2012.05.002. Epub 2012 Jul 9.
8
Strategies for development of Dengue virus inhibitors.登革热病毒抑制剂的研发策略。
Antiviral Res. 2010 Mar;85(3):450-62. doi: 10.1016/j.antiviral.2009.12.011. Epub 2010 Jan 8.
9
CLEC5A is critical for dengue-virus-induced lethal disease.CLEC5A对登革病毒诱导的致死性疾病至关重要。
Nature. 2008 May 29;453(7195):672-6. doi: 10.1038/nature07013. Epub 2008 May 21.
10
Strategies for the treatment of dengue virus infections: a narrative account.登革热病毒感染的治疗策略:叙述性描述。
Future Med Chem. 2010 Apr;2(4):601-8. doi: 10.4155/fmc.10.15.

引用本文的文献

1
Current status of the development of dengue vaccines.登革热疫苗的发展现状。
Vaccine X. 2024 Dec 17;22:100604. doi: 10.1016/j.jvacx.2024.100604. eCollection 2025 Jan.
2
Randomized single oral dose phase 1 study of safety, tolerability, and pharmacokinetics of Iminosugar UV-4 Hydrochloride (UV-4B) in healthy subjects.随机单剂量口服 1 期研究健康受试者中 iminosugar UV-4 盐酸盐(UV-4B)的安全性、耐受性和药代动力学。
PLoS Negl Trop Dis. 2022 Aug 8;16(8):e0010636. doi: 10.1371/journal.pntd.0010636. eCollection 2022 Aug.
3
Glucosylceramide synthase inhibitors prevent replication of SARS-CoV-2 and influenza virus.
葡萄糖神经酰胺合成酶抑制剂可预防 SARS-CoV-2 和流感病毒的复制。
J Biol Chem. 2021 Jan-Jun;296:100470. doi: 10.1016/j.jbc.2021.100470. Epub 2021 Feb 25.
4
Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?抗冠状病毒药物:治疗新型冠状病毒肺炎(SARS-CoV-2)的候选药物?
Front Microbiol. 2020 Aug 13;11:1818. doi: 10.3389/fmicb.2020.01818. eCollection 2020.
5
The case for re-examining glycosylation inhibitors, mimetics, primers and glycosylation decoys as antivirals and anti-inflammatories in COVID19.重新审视糖基化抑制剂、模拟物、引物和糖基化诱饵作为COVID-19抗病毒和抗炎药物的理由。
Glycobiology. 2020 Sep 28;30(10):763-767. doi: 10.1093/glycob/cwaa083.
6
Validation of a Novel Zebrafish Model of Dengue Virus (DENV-3) Pathology Using the Pentaherbal Medicine Denguenil Vati.利用五草药 Denguenil Vati 对登革热病毒(DENV-3)病理学的新型斑马鱼模型进行验证。
Biomolecules. 2020 Jun 28;10(7):971. doi: 10.3390/biom10070971.
7
Iminosugars counteract the downregulation of the interferon γ receptor by dengue virus.免疫抑制剂抑制登革病毒下调干扰素 γ 受体。
Antiviral Res. 2019 Oct;170:104551. doi: 10.1016/j.antiviral.2019.104551. Epub 2019 Jul 12.
8
EFR-Mediated Innate Immune Response in is a Useful Tool for Identification of Novel ERQC Modulators.内质网相关降解(EFR)介导的固有免疫反应是鉴定新型内质网质量控制(ERQC)调节剂的有用工具。
Genes (Basel). 2018 Dec 27;10(1):15. doi: 10.3390/genes10010015.
9
Mechanisms of Antiviral Activity of Iminosugars Against Dengue Virus.脒糖类抗病毒活性的机制对登革热病毒。
Adv Exp Med Biol. 2018;1062:277-301. doi: 10.1007/978-981-10-8727-1_20.
10
An integrated experimental and modeling approach to propose biotinylated PLGA microparticles as versatile targeting vehicles for drug delivery.一种综合实验与建模的方法,提出将生物素化聚乳酸-羟基乙酸共聚物(PLGA)微粒作为药物递送的通用靶向载体。
Prog Biomater. 2013 Feb 13;2(1):3. doi: 10.1186/2194-0517-2-3.